Product information and disease descriptionPlace of product in therapyDisease description
Long-term morbidity
7 evidence topics · 7 sources
Dysphagia and nutritional support in early infantile onset
“Many data were missing in the later follow-up of patients (Table 3) but by order of frequency, neurological manifestations included: swallowing troubles (18 patients, 16 of whom required enteral feeding by nasogastric tube or gastrostomy, all before 3 years of age), limb hypertonia (18 patients), cerebellar signs (16 patients), VSGP (14 patients), seizures (12 patients), neuropathic pain (9 patients), gelastic cataplexy (7 patients).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“As for later onset NP-C forms, swallowing troubles were very frequent in EI-NP-C patients, with a need of nutritional support for 88% of untreated patients and 100% of miglustat treated patients, at a similar median age of 2.75 and 2.92 years respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Lower limbs were more severely involved than upper limbs, and medications were poorly efficient using antispastic, antidystonic and antalgic drugs in more than 75% of patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Dysphagia and aspiration across the disease course
“Dysphagia occurs in most NP-C patients at some point in the disease course, ranging in severity from occasional swallowing difficulties to loss of swallowing function necessitating placement of a nasogastric tube or gastrostomy feeding” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Silent aspiration in the NIH NPC1 natural history study
“We aimed to characterize aspiration and silent aspiration in the National Institutes of Health (NIH) NPC1 Natural History Study (NCT00344331).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Silent aspiration occurred in 24/130 (18.4%) participants.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Considering aspiration risk, 27/130 (20.8%) had NIH-PAS > 1, including all silent aspirators.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Mean time to silent aspiration was ~ 10 years from neurologic symptom onset, with no difference by neurological disease onset.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Silent aspiration is common in NPC1 and closely linked to advancing neurologic disease severity than to age-of-onset phenotype.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Functional disability by domain in the registry
“A 6-domain composite disability scale was used to calculate the overall disability score for each neurological form.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Across all with neurological onset, the majority of patients showed moderate to severe impairments in all domains, except for ‘swallowing’ and ‘seizure’.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The composite disability scores were notably higher in patients with early onset neurological signs, particularly in late infantile patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Chronic liver disease, fibrosis, and hepatocellular carcinoma after neonatal liver disease
“Higher liver stiffness measurement scores, suggesting increased risk for liver fibrosis, were associated with a history of significant liver disease in infancy (p = 0.001).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In addition, individuals who had severe liver disease at birth are at higher risk for developing clinically significant liver disease after the neonatal period.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Given multiple reports of hepatocellular carcinoma in individuals with NPC1, those with a history of severe liver disease should be closely monitored.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Gastrointestinal, liver, and other comorbidities in the 2025 guideline
“NPC has the highest early onset penetrance of Crohn's among monogenic diseases due to patients' predisposition to intestinal inflammation.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Although rare in childhood, patients with NPC might have an increased risk of hepatocellular carcinoma (HCC).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Individuals with NPC are at increased risk of hypersalivation/drooling.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“There is an increased prevalence of behavioral problems and other psychiatric disorders, such as anxiety, depression, or psychosis, in NPC.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote